Verastem, Inc. Announces Addition To The NASDAQ Biotechnology Index
Published: Dec 19, 2013
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ:NBI). The addition to the NASDAQ Biotechnology Index will become effective upon market open on December 23, 2013.
Help employers find you! Check out all the jobs and post your resume.